中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

146 records (took 0.029 seconds)

    FATTY ACID TREATMENT FOR CARDIAC PATIENTS
    67.
    发明申请
    FATTY ACID TREATMENT FOR CARDIAC PATIENTS 审中-公开

    公开(公告)号：US20170333376A1

    公开(公告)日：2017-11-23

    申请号：US15587236

    申请日：2017-05-04

    Applicant: Baylor Research Institute

    Inventor： Charles R. ROE

    IPC: A61K31/20 ,  A61K31/19 ,  A61K31/194 ,  A61K31/23

    CPC classification number: A61K31/20 ,  A61K31/19 ,  A61K31/194 ,  A61K31/23

    Abstract: A method of treating patients in need of treatment for a cardiac disorder has been found which comprises administering to the patient a seven carbon fatty acid compound or derivative thereof, wherein the compound or derivative thereof is able to readily enter the mitochondrion without special transport enzymes. A dietary formulation suitable for treatment of heart tissue in cardiac or surgical patients has been found which comprises a seven-carbon fatty acid chain, wherein the seven-carbon fatty acid chain is characterized by the ability to transverse the inner mitochondrial membrane by a transport mechanism which does not require carnitine palmitoyltransferase I, carnitine palmitoyltransferase II, or carnitine/acylcarnitine translocase and the ability to undergo mitochondrial β-oxidation, and wherein the compound is selected from the group consisting of n-heptanoic acid or a derivative thereof, a triglyceride comprising n-heptanoic acid or a derivative thereof, and triheptanoin or a derivative thereof.

    MIR-320E AND COLORECTAL CANCER
    70.
    发明申请
    MIR-320E AND COLORECTAL CANCER 审中-公开
    MIR-320E和COLORECTAL CANCER

    公开(公告)号：US20170067115A1

    公开(公告)日：2017-03-09

    申请号：US15120052

    申请日：2015-02-18

    Applicant: BAYLOR RESEARCH INSTITUTE

    Inventor： Ajay GOEL ,  Lucia PEREZ-CARBONELL ,  C. Richard BOLAND

    IPC: C12Q1/68 ,  C12N15/113 ,  G06F19/00 ,  A61K31/513

    CPC classification number: C12Q1/6886 ,  A61K31/513 ,  C12N15/113 ,  C12N2310/14 ,  C12N2320/30 ,  C12Q2600/118 ,  C12Q2600/158 ,  C12Q2600/178 ,  G06F19/00 ,  G16H10/60 ,  G16H40/63 ,  Y02A90/22 ,  Y02A90/26

    Abstract: Embodiments provide methods and compositions related to determining treatments for colorectal cancer patients by detection and analysis of the expression level of miRNA such as miR-320e in the patients. Embodiments provide predictive, prognostic and/or diagnostics methods by identifying miRNAs that are useful for clinical management of cancer patients, particularly colorectal cancer patients or patients at risk or determined to have colorectal cancer. Methods and compositions are based, in part, on the discovery that expression of certain miRNAs in cancer patients is associated with advancing cancer stages and/or can predict the responsiveness of cancer therapy, and can, therefore, provide basis for designing treatment strategies. In particular embodiments, the miRNA molecule is miR-320, particularly miR-320e.

    Abstract translation: 实施例提供了通过检测和分析患者诸如miR-320e之类的miRNA的表达水平来确定结肠直肠癌患者治疗相关的方法和组合物。 实施例通过鉴定可用于临床治疗癌症患者，特别是结肠直肠癌患者或处于风险中或确定为结肠直肠癌的患者的miRNA来提供预测，预后和/或诊断方法。 方法和组合部分地基于发现癌症患者中某些miRNA的表达与癌症阶段的进展和/或可以预测癌症治疗的反应性相关联，并且因此可以为设计治疗策略提供依据。 在具体实施方案中，miRNA分子是miR-320，特别是miR-320e。

Patent Agency Ranking